These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 21386016

  • 21. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M, Sekar U.
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S, Mallick SK, Bose S.
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [Abstract] [Full Text] [Related]

  • 24. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
    Chayakulkeeree M, Junsriwong P, Keerasuntonpong A, Tribuddharat C, Thamlikitkul V.
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1503-9. PubMed ID: 16610653
    [Abstract] [Full Text] [Related]

  • 25. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
    Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM.
    Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
    [Abstract] [Full Text] [Related]

  • 26. Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
    Marra AR, Pereira CA, Castelo A, do Carmo Filho JR, Cal RG, Sader HS, Wey SB.
    Int J Infect Dis; 2006 Jan; 10(1):56-60. PubMed ID: 16326126
    [Abstract] [Full Text] [Related]

  • 27. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ, Rojtman A, Tran K.
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):313-5. PubMed ID: 17084784
    [Abstract] [Full Text] [Related]

  • 28. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
    Lee CH, Su LH, Tang YF, Liu JW.
    J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
    [Abstract] [Full Text] [Related]

  • 29. Impact of extended spectrum beta-lactamase producing Klebsiella pneumoniae infections in severely burned patients.
    Bennett JW, Robertson JL, Hospenthal DR, Wolf SE, Chung KK, Mende K, Murray CK.
    J Am Coll Surg; 2010 Sep; 211(3):391-9. PubMed ID: 20800197
    [Abstract] [Full Text] [Related]

  • 30. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
    Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E.
    Clin Infect Dis; 2005 May 01; 40(9):1317-24. PubMed ID: 15825035
    [Abstract] [Full Text] [Related]

  • 31. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.
    Clin Infect Dis; 2001 Apr 15; 32(8):1162-71. PubMed ID: 11283805
    [Abstract] [Full Text] [Related]

  • 32. [Analysis of antibiotics treatment in 86 cases of liver transplant recipients].
    Liu ZG, Gong HY, Zhou JD, Zhang HY.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 15; 17(11):852-5. PubMed ID: 19958647
    [Abstract] [Full Text] [Related]

  • 33. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
    Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, Arnan M, Marin M, Carratalà J, Gudiol F.
    J Antimicrob Chemother; 2010 Feb 15; 65(2):333-41. PubMed ID: 19959544
    [Abstract] [Full Text] [Related]

  • 34. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit.
    Le J, Nguyen T, Okamoto M, McKamy S, Lieberman JM.
    Pediatr Infect Dis J; 2008 Apr 15; 27(4):314-8. PubMed ID: 18316990
    [Abstract] [Full Text] [Related]

  • 35. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D, De Bels D, Forêt F, Cran S, Gilbert E, Schoonheydt K, Blot S, ANTHICUS Study Investigators.
    Int J Antimicrob Agents; 2010 Apr 15; 35(4):375-81. PubMed ID: 20122817
    [Abstract] [Full Text] [Related]

  • 36. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI, Lee NY, Yan JJ, Lee HC, Ko NY, Chang CM, Wu CJ, Chen PL, Wang LR, Ko WC.
    J Microbiol Immunol Infect; 2009 Aug 15; 42(4):303-9. PubMed ID: 19949753
    [Abstract] [Full Text] [Related]

  • 37. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
    Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, Cruzado JM, Carratalà J.
    Transplantation; 2013 Nov 15; 96(9):843-9. PubMed ID: 23883973
    [Abstract] [Full Text] [Related]

  • 38. Extended-spectrum beta-lactamases and clinical outcomes: current data.
    Ramphal R, Ambrose PG.
    Clin Infect Dis; 2006 Apr 15; 42 Suppl 4():S164-72. PubMed ID: 16544267
    [Abstract] [Full Text] [Related]

  • 39. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Lee NY, Huang WH, Tsui KC, Hsueh PR, Ko WC.
    Diagn Microbiol Infect Dis; 2011 May 15; 70(1):150-3. PubMed ID: 21398070
    [Abstract] [Full Text] [Related]

  • 40. Extended spectrum β-lactamase-producing Enterobacteriaceae infection in heart and lung transplant recipients and in mechanical circulatory support recipients.
    Bui KT, Mehta S, Khuu TH, Ross D, Carlson M, Leibowitz MR, Schaenman JM, Saggar R, Lynch JP, Ardehali A, Kubak BM.
    Transplantation; 2014 Mar 15; 97(5):590-4. PubMed ID: 24162251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.